Tag:

Vaccine Development

COVID-19: Westport School District Extends Winter Break For Students As It Weighs Options COVID-19: Westport School District Extends Winter Break For Students As It Weighs Options
Covid-19: Westport School District Extends Winter Break For Students As It Weighs Options A school district in Connecticut is extending winter break for students as it assesses a sharp increase in COVID-19 cases. The announcement by the Westport School District came on Friday afternoon, Dec. 31. The district said it will extend the winter break by one day for all students and that Monday, Jan. 3 will not be a school day for students. All faculty and staff will report on Monday. "This will enable the district to work collaboratively to develop a range of responses to the changing conditions over the coming weeks," Westport Superintendent of Schools Thomas Scarice said …
COVID-19: 'Omicron's A Different Animal,' Says Expert, Sounding Alarm Over In-Person Learning COVID-19: 'Omicron's A Different Animal,' Says Expert, Sounding Alarm Over In-Person Learning
Covid-19: 'Omicron's A Different Animal,' Says Expert, Sounding Alarm Over In-Person Learning A pediatrician who is an expert on disease and vaccine development is sounding the alarm about the ability of schools to resume in-person learning during the height of the new wave of the COVID-19 pandemic sparked by a surge of cases from the highly contagious Omicron variant. Connecticut native Dr. Peter Hotez is the dean of the National School of Tropical Medicine at the Baylor College of Medicine and co-director of the Texas Children's Hospital Center for Vaccine Development. "Here's the problem," Hotez said in an interview on MSNBC Wednesday morning, Dec. 29. "We're kind of going off ol…
COVID-19: Booster Shot Significantly Raises Antibody Levels Against Omicron, Moderna Says COVID-19: Booster Shot Significantly Raises Antibody Levels Against Omicron, Moderna Says
Covid-19: Booster Shot Significantly Raises Antibody Levels Against Omicron, Moderna Says A Moderna COVID-19 vaccine booster shot significantly raises the level of antibodies against the new Omicron variant, the company announced on Monday morning, Dec. 20. The currently authorized 50-microgram booster neutralized antibody levels against Omicron approximately 37-fold compared to pre-boost levels and a 100-micrograms dose increased neutralizing antibody levels approximately 83-fold compared to pre-boost levels, the Cambridge, Massachusetts-based company said in a statement. The results are based on laboratory testing. “The dramatic increase in COVID-19 cases from the O…